Source: Fortune
Summary
Asia’s healthcare market is expected to reach $5 trillion by 2030, but governments are not investing enough in public healthcare, creating a massive funding gap. Non-communicable diseases are on the rise in Southeast Asia, with 8.5 million lives lost annually. Private capital is filling the gap, with firms like Quadria Capital investing in health companies across the region. Asia is also moving up the biopharma value chain, with China and South Korea leading the way.
Our Reading
The numbers tell one story.
Asia’s healthcare market is growing, but governments are not keeping pace with public health spending. Private capital is stepping in, with Quadria Capital’s Abrar Mir saying that 70% of hospital beds in Malaysia are funded by the corporate sector. The region is also seeing innovation in biopharma, with China and South Korea leading the way. But Southeast Asia is still lagging behind. Mir concludes that Asia’s health sector holds immense potential, but companies must have a clear strategy in the region to remain global leaders.
Private capital is filling the healthcare funding gap, but will it be enough to address the region’s growing health needs?
Author: Evan Null
